NIAID announces revised priorities for HIV vaccine research
Friday, July 25, 2008 - 09:56
in Health & Medicine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is reshaping its research enterprise to broaden HIV vaccine discovery activities. Many of the initiatives have evolved from ideas and opinions recently expressed by scientists either at NIAID's HIV Vaccine Summit on March 25 or in response to two Requests for Information that NIAID issued in April.
Read the whole article on Biology News Net
More from Biology News Net
Related
- NIAID announces revised priorities for HIV vaccine researchThu, 24 Jul 2008, 17:36:46 EDT
- NIAID will not move forward with the PAVE 100 HIV Vaccine TrialThu, 17 Jul 2008, 11:23:52 EDT
- IAVI statement in response to NIAID decision not to move forward with PAVE 100 HIV Vaccine TrialThu, 17 Jul 2008, 12:14:46 EDT
- NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidatesWed, 22 Jul 2009, 13:46:33 EDT
- NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthmaFri, 9 Oct 2009, 17:36:46 EDT